slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 86,341-86,370
Pages 3,685
Rows per page 30
Component
86,341-86,370 of 110,539
27
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a circular graphic featuring patient photos to emphasize the human-centric approach.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Golden Circle1 hit
09
Includes a 3-step mechanism of action diagram.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
11
The slide uses a hub-and-spoke style diagram to organize strategic pillars.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
04
Slide 4 of a presentation, likely AstraZeneca.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
06
Uses a 2x2 grid layout to categorize capital allocation strategies.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
07
The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
10
Includes clinical trial data visualization and deal structure details.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Thesis HeadlineLoop · Golden Circle1 hit
14
The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
03
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
06
The slide uses a timeline framework to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Roadmap1 hit
08
Uses a vertical timeline-style list to present the 'Huge Need for Development' metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate clinical progression and de-risking.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The chart displays pharmacodynamic data with error bars and significance markers (asterisks).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
The slide uses a structured card-based layout to present four distinct business units.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
The slide uses a three-column layout to define the business model and provides quantitative evidence for each pillar at the bottom.Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · Setup1 hit
07
The funnel represents a care delivery hierarchy. The right side shows a visual correlation between care level, cost ($), and population size (Millions).Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
09
The slide uses a four-column layout to categorize capabilities, supported by a row of key performance metrics at the bottom.Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · Evidence1 hit
14
The chart highlights a 4.8x YoY VBC revenue growth and a shift in revenue mix towards Medicare and commercial populations.Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
05
The central diagram represents a knowledge graph or network of interconnected biological data points.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a process flow diagram to explain the platform's methodology.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
09
The central diagram acts as a template for hypothesis generation: 'Can we treat [Target] by [Sign] [Mechanism] in [Cell type] by [Sign] [Mechanism]?'BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
10
The diagram shows a process flow from data inputs to model processing to target identification.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
11
The slide uses a combination of UI screenshots and a list of benefits to illustrate the platform's capabilities.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit